Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

18.770
-1.230-6.15%
Volume:10.01M
Turnover:189.98M
Market Cap:21.36B
PE:-14.94
High:19.990
Open:19.990
Low:18.630
Close:20.000
52wk High:27.280
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:2.00
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.257
ROE:-26.91%
ROA:-14.75%
PB:4.49
PE(LYR):-14.94
PS:6.06

Loading ...

Zai Lab - Q2 2026 Net Loss $50.80 Mln, Loss Per Share $0.05, Loss Per Ads $0.46

THOMSON REUTERS
·
Aug 06

Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

THOMSON REUTERS
·
Aug 06

Zai Lab - Q2 2026 Total Revenue $106.30 Mln vs $110 Mln in Q2 2025

THOMSON REUTERS
·
Aug 06

Zai Lab Reports Flat Share Count for July 2026; 1.14 B Issued Shares, No New Equity Raised

Bulletin Express
·
Aug 06

Zai Lab Says FDA Grants Orphan Drug Designation for DLL3 ADC Zocilurtatug Pelitecan in Neuroendocrine Carcinomas

Reuters
·
Aug 03

Earning Preview: ZAI LAB Q2 revenue expected to decline by 16.16%, institutions lean cautious on profitability trajectory

Earnings Agent
·
Jul 31

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Asian Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live
·
Jul 29

Zai Lab Sets 6 Aug Audit Committee Review and Immediate Release of 2026 Interim Results

Bulletin Express
·
Jul 24

Movement Alert|ZAI LAB Falls 5.05% in Regular Trading, Multiple Banks Cut Target Prices Amid Biotech Sector Weakness

Market Focus
·
Jul 24

Zai Lab Updates Financial Calendar with Upcoming Earnings Release and Conference Call

Reuters
·
Jul 22

Movement Alert|Zai Lab Falls 5.05% in Regular Trading, Trading at HK$15.3

Market Focus
·
Jul 17

Movement Alert|Zai Lab Rises 5.05% in Regular Trading, Trading at HK$16.19

Market Focus
·
Jul 16

Movement Alert|Zai Lab Falls 5.29% in Regular Trading, Trading at HK$15.05

Market Focus
·
Jul 14

Movement Alert|Zai Lab Rises 5.15% in Regular Trading, Medical Insurance Policy Boost Drives Innovative Drug Sector Higher

Market Focus
·
Jul 10

Movement Alert|Zai Lab Rises 5.09% in Regular Trading, Innovative Drug Sector Broadly Higher on Medical Insurance Policy Tailwinds

Market Focus
·
Jul 08

Zai Lab Director Richard Gaynor Acquires 1,736 Shares for $33,070.8

Reuters
·
Jul 07

Zai Lab grants 2,000 ADS options and 84,893 ADS RSUs under 2024 plan

Bulletin Express
·
Jul 03

Movement Alert|Zai Lab Falls 5.04% in Regular Trading, Partner Novocure Clinical Failure Continues to Weigh on Sentiment

Market Focus
·
Jun 26

Zai Lab Director William Lis Disposes of 7,040 Shares for $127,353.6

Reuters
·
Jun 25